Qiagen snagged FDA approval for its test for AstraZeneca's lung cancer drug, building on its previous relationship with the biotech titan to claim more ground in the companion diagnostics field.
Qiagen relies on companion diagnostics to keep its engine running, and the company is looking to gain some ground in the field through a new joint venture with German molecular diagnostics outfit Biotype Diagnostic.
Qiagen will combine its expertise in assays and biomarker panels with Hitachi's knowledge of instrumentation and manufacturing to advance research-based and clinical molecular testing via a strategic collaboration.
HalioDx, a new company focused on cancer companion diagnostics, is kicking off operations after a management buyout at Qiagen's Marseille subsidiary.
Qiagen pointed to a study in The Lancet showing that its Quantiferon-TB Gold tuberculosis test is more accurate at detecting tuberculosis than the traditional tuberculin skin test, which the company said is overestimating the prevalence of the disease in China.
With its recent acquisition of diagnostics outfit Enzymatics, Dutch Qiagen has gained another strategic partner--the newly formed company ArcherDX, which will focus solely on developing next-generation sequencing products.
Qiagen has been winning critical regulatory approvals for new tests and inking companion diagnostics deals to expand its market reach. The company has exceeded its goal of 250 new placements for its modular molecular testing system in 2014 and is hedging its bets on growth in the coming year.
German Qiagen ($QGEN) is stepping up to help laboratories respond to the ongoing Ebola outbreak in West Africa. The company said it has partnered with Germany's Altona Diagnostics to distribute an Ebola test both in and outside the U.S.
With its sights set on growth, German diagnostics outfit Curetis AG has closed a $18.1 million Series B financing round with new investor Qiagen chipping in.
Hot on the trail of companion diagnostics partnerships, Qiagen is teaming up with pharma bigwig Novartis to develop tests for the company's drug portfolio.